
From 2D to 3D cell cultures
Why and how? From 2D to 3D cell cultures : The main issues found while using
Why and how? From 2D to 3D cell cultures : The main issues found while using
Cherry Biotech Organ-on-a-Chip technologies mentioned as an alternative to animal drug testing by Yannick Jadot during
Efficacity and toxicity of candidate anticancer drugs on 3D cell culture model has been much lower
Organs-on-Chip for Drug Development A drug should pass the preclinical evaluation phase to be FDA-approved. This
Introduction Drug induced liver injury (DILI)is one of the major reasons of drug attrition and it
Introduction The liver is a fundamental organ for human life. It is responsible for macromolecules (carbohydrates,
Introduction In this paper, Mehnert JM and colleagues discussed the new advances in immuno-oncology and related biomarkers
Introduction Weak protein-protein interactions are a common phenomenon inside cells. Besides being well known, it has a crucial
Introduction: Trueness, accuracy and precision The words accuracy, trueness and precision are important differentiated terms when referring to measurements in the scientific and
Introduction The ultimate goal in microfluidics is to achieve the so-called laboratory-on-a-chip, i.e. integrate all those activities
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com
All right reserved to © Cherry Biotech 2023